In skeletal muscle cells, this transcription factor was associated with the activation of pro-inflammatory immune response in patients with myalgia [44] and with MyHC IIB expression, when associated with MEF2 and the serum response factor (SRF) [45–47]. The gene discussed is MEF2A; the disease is Myalgia.